Bristol-Myers Squibb Co. (BMY)

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., current price multiples

Based on: 10-K (filing date: 2018-02-13).

If company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.

Otherwise, if company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., historical price multiples

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

Ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	Bristol-Myers Squibb Co.’s P/E ratio declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	Bristol-Myers Squibb Co.’s P/OP ratio declined from 2015 to 2016 but then slightly increased from 2016 to 2017.
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	Bristol-Myers Squibb Co.’s P/S ratio declined from 2015 to 2016 but then slightly increased from 2016 to 2017.
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return.	Bristol-Myers Squibb Co.’s P/BV ratio declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., historical P/E calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	Bristol-Myers Squibb Co.’s P/E ratio declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., historical P/OP calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	Bristol-Myers Squibb Co.’s P/OP ratio declined from 2015 to 2016 but then slightly increased from 2016 to 2017.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., historical P/S calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	Bristol-Myers Squibb Co.’s P/S ratio declined from 2015 to 2016 but then slightly increased from 2016 to 2017.

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., historical P/BV calculation, comparison to benchmarks

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).

2017 Calculations

Ratio	Description	The company
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return.	Bristol-Myers Squibb Co.’s P/BV ratio declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.